{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:11:24Z","timestamp":1785010284183,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002653","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["L403"],"award-info":[{"award-number":["L403"]}],"id":[{"id":"10.13039\/501100002653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,7,31]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Interstitial lung abnormalities (ILA) are relatively common incidental findings in participants undergoing low-dose CT screening for lung cancer. Some ILA are transient and inconsequential, but others represent interstitial lung disease (ILD). Lung cancer screening therefore offers the opportunity of earlier diagnosis and treatment of ILD for some screening participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The prevalence of ILA in participants in the baseline screening round of the Yorkshire Lung Screening Trial is reported, along with the proportion referred to a regional ILD service, eventual diagnoses, outcomes and treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 6650 participants undergoing screening, ILA were reported in 169 (2.5%) participants. Following review in a screening review meeting, 56 participants were referred to the ILD service for further evaluation (0.8% of all screening participants). 2 participants declined referral, 1 is currently awaiting review and the remaining 53 were confirmed as having ILD. Eventual diagnoses were idiopathic pulmonary fibrosis (n=14), respiratory bronchiolitis ILD (n=4), chronic hypersensitivity pneumonitis (n=2), connective tissue disease\/rheumatoid arthritis-related ILD (n=4), asbestosis (n=1), idiopathic non-specific interstitial pneumonia (n=1), sarcoidosis (n=1) and pleuroparenchymal fibroelastosis (n=1). Twenty five patients had unclassifiable idiopathic interstitial pneumonia. Overall, 10 people received pharmacotherapy (7 antifibrotics and 3 prednisolone) representing 18% of those referred to the ILD service and 0.15% of those undergoing screening. 32 people remain under surveillance in the ILD service, some of whom may require treatment in future.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Lung cancer screening detects clinically significant cases of ILD allowing early commencement of disease-modifying treatment in a proportion of participants. This is the largest screening cohort to report eventual diagnoses and treatments and provides an estimate of the level of clinical activity to be expected by ILD services as lung cancer screening is implemented. Further research is needed to clarify the optimal management of screen-detected ILD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN42704678\">ISRCTN42704678<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001490","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:20:55Z","timestamp":1692789655000},"page":"e001490","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"isrctn42704678","registry":"10.18810\/isrctn"},{"clinical-trial-number":"isrctn42704678","registry":"10.18810\/isrctn"}],"author":[{"given":"Sara","family":"Upperton","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Beirne","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Bhartia","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Boland","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9184-103X","authenticated-orcid":false,"given":"Claire","family":"Bradley","sequence":"additional","affiliation":[{"name":"Craigavon Area Hospital, Southern Health and Social Care Trust, Portadown, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-4813","authenticated-orcid":false,"given":"Philip A J","family":"Crosbie","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Darby","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Eckert","sequence":"additional","affiliation":[{"name":"Leeds Diagnosis and Screening Unit, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-3094","authenticated-orcid":false,"given":"Rhian","family":"Gabe","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Hancock","sequence":"additional","affiliation":[{"name":"Leeds Diagnosis and Screening Unit, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn P T","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lindop","sequence":"additional","affiliation":[{"name":"Department of Research and Innovation, Leeds Teaching Hospitals Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Rogerson","sequence":"additional","affiliation":[{"name":"Department of Research and Innovation, Leeds Teaching Hospitals Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1018","authenticated-orcid":false,"given":"Bethany","family":"Shinkins","sequence":"additional","affiliation":[{"name":"Leeds Diagnosis and Screening Unit, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Simmonds","sequence":"additional","affiliation":[{"name":"Leeds Diagnosis and Screening Unit, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J T","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-0803","authenticated-orcid":false,"given":"Matthew E J","family":"Callister","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"2025083110242672000_10.1.e001490.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"2025083110242672000_10.1.e001490.2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-6-201309170-00690"},{"key":"2025083110242672000_10.1.e001490.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"2025083110242672000_10.1.e001490.4","unstructured":"UK National Screening Committee . Lung cancer screening recommendation. 2022. Available: https:\/\/view-health-screening-recommendations.service.gov.uk\/lung-cancer\/"},{"key":"2025083110242672000_10.1.e001490.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2022.08.017","article-title":"Incidental findings in low dose CT lung cancer screening of high-risk Smokers: results from the Manchester lung health check pilot","volume":"173","author":"Bradley","year":"2022","journal-title":"Lung Cancer"},{"key":"2025083110242672000_10.1.e001490.6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13120816"},{"key":"2025083110242672000_10.1.e001490.7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025083110242672000_10.1.e001490.8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2512081242"},{"key":"2025083110242672000_10.1.e001490.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.1.9001319"},{"key":"2025083110242672000_10.1.e001490.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.06.041"},{"key":"2025083110242672000_10.1.e001490.11","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14148"},{"key":"2025083110242672000_10.1.e001490.12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1513\/AnnalsATS.201801-053RL","article-title":"Underreporting of interstitial lung abnormalities on lung cancer screening computed tomography","volume":"15","author":"Oldham","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2025083110242672000_10.1.e001490.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"2025083110242672000_10.1.e001490.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2025083110242672000_10.1.e001490.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2025083110242672000_10.1.e001490.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00201809"},{"key":"2025083110242672000_10.1.e001490.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037075","article-title":"Yorkshire lung screening trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk","volume":"10","author":"Crosbie","year":"2020","journal-title":"BMJ Open"},{"key":"2025083110242672000_10.1.e001490.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001764","article-title":"Evaluation of the lung cancer risks at which to screen Ever- and never-Smokers: screening rules applied to the PLCO and NLST cohorts","volume":"11","author":"Tammem\u00e4gi","year":"2014","journal-title":"PLoS Med"},{"key":"2025083110242672000_10.1.e001490.19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604158"},{"key":"2025083110242672000_10.1.e001490.20","unstructured":"National Institute for Health and Care Excellence . Pirfenidone for treating idiopathic pulmonary fibrosis. NICE technology appraisal guidance. 2018. Available: www.nice.org.uk\/guidance\/ta504"},{"key":"2025083110242672000_10.1.e001490.21","unstructured":"National Institute for Health and Care Excellence . Nintedanib for treating idiopathic pulmonary fibrosis. NICE technology appraisal guidance. 2016. Available: www.nice.org.uk\/guidance\/ta379"},{"key":"2025083110242672000_10.1.e001490.22","unstructured":"National Institute for Health and Care Excellence . Nintedanib for treating progressive Fibrosing interstitial lung diseases. NICE technology appraisal guidance. 2021. Available: www.nice.org.uk\/guidance\/ta747"},{"key":"2025083110242672000_10.1.e001490.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.07.012"},{"key":"2025083110242672000_10.1.e001490.24","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219068"},{"key":"2025083110242672000_10.1.e001490.25","unstructured":"NHS England . Targeted screening for lung cancer with low radiation dose computed tomography. 2019. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/02\/targeted-lung-health-checks-standard-protocol-v1.pdf"},{"key":"2025083110242672000_10.1.e001490.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037086","article-title":"Yorkshire enhanced stop smoking (YESS) study: A protocol for a randomised controlled trial to evaluate the effect of adding a Personalised smoking cessation intervention to a lung cancer screening programme","volume":"10","author":"Murray","year":"2020","journal-title":"BMJ Open"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:24:32Z","timestamp":1756661072000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,23]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/bmjresp-2022-001490"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001490","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}